Fingerprint
Dive into the research topics of 'A Randomized, Phase II Trial of Cetuximab With or Without PX-866, an Irreversible Oral Phosphatidylinositol 3-Kinase Inhibitor, in Patients With Metastatic Colorectal Carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically